SB-399885 hydrochloride is a 5-HT6 receptor antagonist used to promote wakefulness and modulate sleep architecture, including reducing slow-wave sleep (SWS), rapid-eye-movement sleep (REMS), and the number of REM periods, as well as increasing REMS latency.